Physician profile
David Haley
NPI 1750371159
$6,104.35
in general payments reported to CMS, 2019-2025
42 companies · $886 in 2025
The $886 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $728 · 2020: $359 · 2021: $2,236 · 2022: $703 · 2023: $859 · 2024: $334 · 2025: $886.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,079.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,078.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ossio INC | $1,838.57 | 2021 | |
| Stryker Corporation | $742.82 | 2019-2025 | Citrefix, Prophecy, Prostep Mica |
| Smith+Nephew, INC. | $665.34 | 2019-2025 | Stravix Mesh, Collagenase Santyl, Regranex |
| Medtronic, INC. | $436.40 | 2022-2025 | Intellis Adaptivestim, Inceptiv |
| Sandoz INC. | $320.65 | 2019-2021 | |
| Osteomed LLC | $288.92 | 2019-2021 | |
| Bioventus LLC | $144.05 | 2020-2025 | Exogen Ultrasound Bone Healing System |
| Cardiovascular Systems INC. | $127.67 | 2022 | |
| Vaporox, INC. | $105.31 | 2023 | Vht-200 Wound Treatment System |
| Sebela Pharmaceuticals INC. | $100.51 | 2019-2023 | Naftin |
| Eclipse Technology Solutions INC. | $96.90 | 2023-2025 | |
| Kerecis Limited | $95.58 | 2019-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Paratek Pharmaceuticals, INC. | $94.27 | 2024-2025 | Nuzyra |
| Organogenesis INC. | $85.54 | 2019-2025 | Apligraf |
| Depuy Synthes Sales INC. | $80.84 | 2019-2022 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Haley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.